[go: up one dir, main page]

Previous Issue
Volume 5, June
 
 

J. Nanotheranostics, Volume 5, Issue 3 (September 2024) – 3 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
5 pages, 191 KiB  
Opinion
Anti-Poly(ethylene glycol) (PEG) Antibodies: From Where Are We Coming and Where Are We Going
by Dmitri Simberg and S. Moein Moghimi
J. Nanotheranostics 2024, 5(3), 99-103; https://doi.org/10.3390/jnt5030007 - 29 Jul 2024
Viewed by 312
Abstract
PEGylation technology confers stability and modulates the biological performance of a broad range of preclinical and clinical nanopharmaceuticals. However, the emerging PEG immunogenicity in the general population is thought to impact the efficacy and safety of PEGylated medicines. Despite this, the clinical significance [...] Read more.
PEGylation technology confers stability and modulates the biological performance of a broad range of preclinical and clinical nanopharmaceuticals. However, the emerging PEG immunogenicity in the general population is thought to impact the efficacy and safety of PEGylated medicines. Despite this, the clinical significance of PEG immunogenicity is still not clear and remains debatable. By considering the strategic importance of the PEGylation technology in nanopharmaceutical engineering, we raise a number of critical questions and briefly discuss gaps in the knowledge of PEG immunogenicity and its clinical significance. Full article
15 pages, 6371 KiB  
Review
Paradoxical Roles of Carbon Nanotubes in Cancer Therapy and Carcinogenesis
by Bohan Xu, Shunjie Wu, Yiyang Wang, Yuhe Ji, Shufeng Liang, Chunyan Wang and Xin Tian
J. Nanotheranostics 2024, 5(3), 84-98; https://doi.org/10.3390/jnt5030006 - 8 Jul 2024
Viewed by 558
Abstract
Carbon nanotubes (CNTs), members of the nanomaterial family, are increasingly being used in consumer products and extensively studied for various biomedical applications. Due to their benign elemental composition, large surface area, and chemical and biological activities, CNTs demonstrate great potential in cancer therapy, [...] Read more.
Carbon nanotubes (CNTs), members of the nanomaterial family, are increasingly being used in consumer products and extensively studied for various biomedical applications. Due to their benign elemental composition, large surface area, and chemical and biological activities, CNTs demonstrate great potential in cancer therapy, including drug delivery, imaging analysis, photothermal therapy, photodynamic therapy, and radiotherapy. However, there is still a major knowledge gap when it comes to transitioning from research to clinical applications. One of the important issues is that the biological toxicity of CNTs, especially in terms of carcinogenesis, and the underlying mechanisms are not fully understood. Therefore, a thorough evaluation of toxicity and the underlying mechanisms of carcinogenesis is essential to enable the wide application of CNTs. In this review, we summarize the recent progress of CNTs as multifunctional therapeutics in cancer therapy. Furthermore, a detailed discussion is provided on the carcinogenesis and potential mechanisms of CNTs. Finally, the review ends with further challenges and prospects for CNTs with the expectation of facilitating their broader utilization. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Functionalized SWCNTs loaded with drugs or gene products enter the cell, releasing the drugs or gene products into the cytoplasm [<a href="#B25-jnt-05-00006" class="html-bibr">25</a>]. Reproduced with permission from ref. [<a href="#B25-jnt-05-00006" class="html-bibr">25</a>]. Copyright © 2020 Elsevier. (<b>B</b>) TEM images of SWCNTs loaded with plasmid DNA [<a href="#B26-jnt-05-00006" class="html-bibr">26</a>]. (<b>a</b>) TEM image of SWCNTs. (<b>b</b>,<b>c</b>) TEM images of SWCNTs loaded with plasmid DNA. Globular and supercoiled structures of plasmid DNA (black arrows in (<b>b</b>,<b>c</b>)). Tighter packing of the SWCNTs (white arrows in (<b>c</b>)). Reproduced with permission from ref. [<a href="#B26-jnt-05-00006" class="html-bibr">26</a>]. Copyright © 2004 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim, respectively.</p>
Full article ">Figure 2
<p>CNTs for cancer therapy. (<b>A</b>) Au combined with SWCNTs enhances the sensitivity of cancer cells to X-rays [<a href="#B33-jnt-05-00006" class="html-bibr">33</a>]. Reproduced with permission from ref. [<a href="#B33-jnt-05-00006" class="html-bibr">33</a>]. Copyright © 2020 Elsevier. (<b>B</b>) Ru@SWCNTs are developed for bimodal PTT and PDT [<a href="#B36-jnt-05-00006" class="html-bibr">36</a>]. Reproduced with permission from ref. [<a href="#B36-jnt-05-00006" class="html-bibr">36</a>]. Copyright © 2015 American Chemical Society.</p>
Full article ">Figure 3
<p>Schematic diagram of CNTs for the regulation of immunity [<a href="#B38-jnt-05-00006" class="html-bibr">38</a>]. Reproduced with permission from ref. [<a href="#B38-jnt-05-00006" class="html-bibr">38</a>]. Copyright © 2024 Formstack, LLC.</p>
Full article ">Figure 4
<p>Molecular imaging methods based on CNTs. (<b>A</b>) Encapsulation of SPIO in the center of polymer-modified MWCNTs by a microwave reaction [<a href="#B48-jnt-05-00006" class="html-bibr">48</a>]. Reproduced with permission from ref. [<a href="#B48-jnt-05-00006" class="html-bibr">48</a>]. Copyright © 2015, American Chemical Society. (<b>B</b>) An inner view of a CNT dynamic micro-CT scanner [<a href="#B50-jnt-05-00006" class="html-bibr">50</a>]. (<b>a</b>,<b>c</b>) CT slice images at the diastolic phase. (<b>b</b>,<b>d</b>) CT slice images at the systolic phase. Reproduced with permission from ref. [<a href="#B50-jnt-05-00006" class="html-bibr">50</a>]. Copyright © 2018, AIP Publishing, respectively.</p>
Full article ">Figure 5
<p>Schematic illustration of how CNTs promote ROS production and induce cell damage. Reprinted from Accounts of Chemical Research [<a href="#B68-jnt-05-00006" class="html-bibr">68</a>]. Reproduced with permission from ref. [<a href="#B68-jnt-05-00006" class="html-bibr">68</a>]. Copyright © 2012 American Chemical Society.</p>
Full article ">Figure 6
<p>Chronic exposure to SWCNTs induces the malignant transformation of epithelial cells [<a href="#B80-jnt-05-00006" class="html-bibr">80</a>]. (<b>A</b>) Dysregulation of DNA methylation leads to carcinogenesis. (<b>B</b>) H&amp;E staining and IHC staining (Ki67, TTF-1, and P63) of malignant transformed tissues. Reproduced with permission from ref. [<a href="#B80-jnt-05-00006" class="html-bibr">80</a>]. Copyright © 2021 American Chemical Society.</p>
Full article ">Figure 7
<p>Schematic illustration of nanoparticles penetrating the endothelium of a blood vessel [<a href="#B86-jnt-05-00006" class="html-bibr">86</a>]. Reproduced with permission from ref. [<a href="#B86-jnt-05-00006" class="html-bibr">86</a>]. Copyright © 2023 Lasak and Ciepluch.</p>
Full article ">
9 pages, 1486 KiB  
Article
Nano-Enabled Colorimetric Assay for the Detection of Paracoccidioides lutzii: Advancing Diagnostics with Nanotechnology
by Olavo O. Comparato Filho, Marcela A. Cândido, Aveline Ventura, Flavia V. Morais and Leandro Raniero
J. Nanotheranostics 2024, 5(3), 75-83; https://doi.org/10.3390/jnt5030005 - 26 Jun 2024
Viewed by 852
Abstract
Deforestation is a common occurrence driven by agricultural expansion, urbanization, and infrastructure development. These activities often lead to increased human interaction with ecosystems, potentially exposing individuals to Paracoccidioides spores (P. brasiliensis and P. lutzii) found in the soil, resulting in Paracoccidioidomycosis [...] Read more.
Deforestation is a common occurrence driven by agricultural expansion, urbanization, and infrastructure development. These activities often lead to increased human interaction with ecosystems, potentially exposing individuals to Paracoccidioides spores (P. brasiliensis and P. lutzii) found in the soil, resulting in Paracoccidioidomycosis (PCM). This fungal infection is endemic to specific regions in Latin America, such as Brazil, Colombia, Venezuela, and Argentina. Diagnosis typically involves a combination of clinical assessment, imaging techniques, and laboratory examinations. P. lutzii lacks the glycoprotein Gp43, a key antigenic protein utilized in serological tests for PCM diagnosis. In this study, a colorimetric test employing gold nanoparticles (AuNPs) and label-free methodology was employed for P. lutzii detection. The effectiveness of the label-free colorimetric test was assessed using a total of 100 samples. This detection was achieved through the amplification of the gp43 gene and the use of a specific probe (5′CAGGGGTGCG3′) in conjunction with AuNPs. The receiver operating characteristic curve was employed to assess the test, revealing that the method can accurately detect P. lutzii with a sensitivity of 100% and a specificity of 100%. The findings indicate a substantial impact on remote endemic regions attributable to the implementation of cost-effective diagnostic methodologies. Full article
Show Figures

Figure 1

Figure 1
<p>Gold nanoparticle characterization: (<b>a</b>) morphology by TEM; (<b>b</b>) hydrodynamic size distribution and zeta potential value; (<b>c</b>) UV–visible spectrum.</p>
Full article ">Figure 2
<p>UV–visible spectra of AuNPs from colorimetric tests. The negative result is the red curve, the positive result is the blue curve, and control AuNPs are shown in black.</p>
Full article ">Figure 3
<p>UV–visible spectra of colorimetric test fitted by the Gaussian equation: (<b>a</b>) Gaussian area; (<b>b</b>) FWHM; (<b>c</b>) Gaussian center.</p>
Full article ">Figure 4
<p>Automatic discrimination of the colorimetric test as determined by Equation (1). The integrated areas of UV–visible spectra were defined by the regions 488–530 nm and 533–575 nm.</p>
Full article ">Figure 5
<p>Receiver operating characteristic curve of the colorimetric tests.</p>
Full article ">
Previous Issue
Back to TopTop